Hero image

About our company

We aspire to be the premier research-intensive biopharmaceutical company

Our purpose: We use the power of leading-edge science to save and improve lives around the world

For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

Our history

our company video
women harvesting tea leaves with basket
Responsibility

The heart of our work

We believe corporate responsibility is about our health, social, environmental and economic impact on people and communities around the world.

Illustration of leaders speaking on stage
Leadership

The team that guides our passion

Our leaders focus on our purpose to use the power of leading-edge science to save and improve lives around the world. This is the foundation of everything we do.

Our company by the numbers

68K

employees

Our culture
$12.2B

research and development investment in 2021

Our research
$3B

total giving in 2020

Our giving
group of scientists working together in lab
Culture & values

Our values are driven by a desire to improve life

We’ve built a culture that embraces scientific excellence, operates with the highest standards of integrity, expands access to our products and employs a diverse workforce that values collaboration.

Black and white photo of George W. Merck
History

Our past and our future

For 130 years, we’ve focused on not just the next quarter, but the next quarter century.

Get to know us through our stories

Learn about the heartbeat of our company.

View our stories

Taking prostate cancer research forward

Scientists at Merck are committed to research and development for people diagnosed with prostate cancer

Read more

Next: Taking prostate cancer research forward

New podcast: The power of one pipeline

Through business development and licensing, Merck Research Laboratories stays primed for new opportunities and partnerships to drive our innovation

Read more

Next: New podcast: The power of one pipeline

How Merck’s OneTen pilot program paved the way for hiring diverse talent

Our Durham, N.C. site became one of the first Merck locations to adopt the OneTen initiative, with the goal of closing the wealth gap for Black Americans

Read more

Next: How Merck’s OneTen pilot program paved the way for hiring diverse talent

Merck’s Q1 2022 earnings report

Merck’s (NYSE: MRK) Q1 2022 results reflect sustained strong business momentum with robust top and bottom- line growth. The company announced Q1 worldwide sales of $15.9 billion, an increase of 50% from Q1 2021. “We successfully delivered across our key strategic priorities and achieved strong top and bottom-line growth,” said chief executive officer and president, Robert […]

Read more

Next: Merck’s Q1 2022 earnings report

Celebrating our Asian American and Pacific Islander colleagues

During Asian American and Pacific Islander (AAPI) Heritage Month and beyond, we’re committed to supporting and saluting our AAPI colleagues and the important work they do

Read more

Next: Celebrating our Asian American and Pacific Islander colleagues

Taking prostate cancer research forward

Scientists at Merck are committed to research and development for people diagnosed with prostate cancer

Read more

Next: Taking prostate cancer research forward

New podcast: The power of one pipeline

Through business development and licensing, Merck Research Laboratories stays primed for new opportunities and partnerships to drive our innovation

Read more

Next: New podcast: The power of one pipeline

How Merck’s OneTen pilot program paved the way for hiring diverse talent

Our Durham, N.C. site became one of the first Merck locations to adopt the OneTen initiative, with the goal of closing the wealth gap for Black Americans

Read more

Next: How Merck’s OneTen pilot program paved the way for hiring diverse talent

Merck’s Q1 2022 earnings report

Merck’s (NYSE: MRK) Q1 2022 results reflect sustained strong business momentum with robust top and bottom- line growth. The company announced Q1 worldwide sales of $15.9 billion, an increase of 50% from Q1 2021. “We successfully delivered across our key strategic priorities and achieved strong top and bottom-line growth,” said chief executive officer and president, Robert […]

Read more

Next: Merck’s Q1 2022 earnings report

Celebrating our Asian American and Pacific Islander colleagues

During Asian American and Pacific Islander (AAPI) Heritage Month and beyond, we’re committed to supporting and saluting our AAPI colleagues and the important work they do

Read more

Next: Celebrating our Asian American and Pacific Islander colleagues

Previous
Next

Our areas of focus

We focus on scientific innovation to deliver medicines and vaccines that may help millions of people around the world.

Oncology

We work to deliver innovations that extend and improve the lives of people with cancer.

Learn about oncology

Vaccines

Vaccines are one of the greatest public health success stories – and we’ve been discovering, developing and delivering vaccines to help prevent disease for over 100 years.

Learn about vaccines

Infectious diseases

We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV and Ebola.

Learn about infectious diseases

COVID-19

As a company dedicated to saving and improving lives, we have a special responsibility to help in the fight against COVID-19. We’ve been fully committed to developing an effective response to the COVID-19 pandemic since it was first recognized.

Learn more about our work in COVID-19

Cardio-metabolic disorders

We are determined to find solutions for the most serious chronic health challenges, such as cardiovascular disease and diabetes.

Learn about cardio-metabolic disorders

Discovery & development

We are pushing the boundaries in research where we can make the greatest difference, now and in the future.

Learn about our work

Dog owner holding out a ball for an attentive Labrador

Merck Animal Health

Merck Animal Health is a research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services.

We offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.

Business partnerships and public policies keep our patients in focus

Column one image

Business development & licensing

We work with partners, from early-stage science to clinical-stage programs, to deliver new therapies to patients.

Column one image

Policies & positions

We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.